cholest-4-en-3-one has been researched along with cholest-5-en-3-one in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakata, T; Shimizu, T; Suzuki, K | 1 |
Alcázar, A; Ayuso, MI; Chioua, M; Hadjipavlou-Litina, DJ; Marco-Contelles, J; Martínez-Alonso, E; Masjuán, J; Montaner, J; Soriano, E | 1 |
Ostman, AL; Slotte, JP | 1 |
3 other study(ies) available for cholest-4-en-3-one and cholest-5-en-3-one
Article | Year |
---|---|
The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice.
Topics: Adipose Tissue; Animals; Cholestenones; Cholesterol; Drug Design; Lipids; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Molecular Structure; Organ Size; Structure-Activity Relationship; Weight Gain | 1998 |
CholesteroNitrones for Stroke.
Topics: Animals; Antioxidants; Brain Ischemia; Cell Death; Cells, Cultured; Cholesterol; Ischemic Attack, Transient; Nervous System Diseases; Neurons; Neuroprotective Agents; Nitrogen Oxides; Rats; Reactive Oxygen Species; Reperfusion Injury; Stroke; Structure-Activity Relationship | 2015 |
Oxidation/isomerization of 5-cholesten-3 beta-ol and 5-cholesten-3-one to 4-cholesten-3-one in pure sterol and mixed phospholipid-containing monolayers by cholesterol oxidase.
Topics: Cholestenones; Cholesterol; Cholesterol Oxidase; Isomerism; Oxidation-Reduction; Phospholipids; Sterols | 1993 |